Skip to Content

Join the 'Toujeo Solostar' group to help and get support from people like you.

Toujeo Solostar News

These Medicines Often Send Americans to ERs

Posted 18 days ago by Drugs.com

TUESDAY, Nov. 22, 2016 – An estimated one in 250 Americans lands in the hospital emergency department each year because of a medication-related reaction or problem, a new federal study finds. Among adults 65 and older, the rate is about one in 100, the study authors said. Remarkably, the medicines causing the most trouble haven't changed in a decade, the researchers noted. Blood thinners, diabetes medicines and antibiotics top the list. These drugs accounted for 47 percent of emergency department visits for adverse drug events in 2013 and 2014, according to the analysis. Among older adults, blood thinners, diabetes medicines and opioid painkillers are implicated in nearly 60 percent of emergency department visits for adverse drug events. "The same drugs are causing the most problems," said study co-author Dr. Daniel Budnitz. The study doesn't tease out what went wrong. The reasons ... Read more

Related support groups: Pain, Back Pain, Suboxone, Oxycodone, Diabetes, Type 2, Hydrocodone, Methadone, Percocet, Tramadol, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Opana, Warfarin, Coumadin, Subutex

Intensive Type 2 Diabetes Treatment Can Extend Survival: Study

Posted 8 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Intensive management of type 2 diabetes can make a difference in how long and how well you live, even if you don't start until middle age, researchers report. People who were already at risk of type 2 diabetes complications were randomly selected to continue with their normal treatment or to be placed in an aggressive and multipronged treatment group. Two decades after the study began, the researchers found that people in the aggressive treatment group lived almost eight years longer. Not only that, they lived better – their risk of heart disease, kidney disease and blindness all dropped. The only complication that didn't seem to improve was nerve damage caused by diabetes. "Early, intensified intervention in type 2 diabetes patients with microalbuminuria with both target-driven pharmacological (medication) and behavioral actions increased life span. And, ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Januvia, Glucophage, Novolog, Glipizide, Humalog, Bydureon, Janumet, Byetta, Saxenda, Glyburide, Lantus Solostar, Invokana, Levemir, Actos, Glimepiride

Intensive Blood Sugar Control May Be Too Much for Some With Type 2 Diabetes

Posted 6 Jun 2016 by Drugs.com

MONDAY, June 6, 2016 – Intensive treatment of blood sugar levels in some people with type 2 diabetes may cause serious complications, new research suggests. "In this study, we found that, particularly among older patients and patients with serious chronic conditions, intensive treatment nearly doubled the risk of severe hypoglycemia requiring medical attention, including hospitalization," said lead author Dr. Rozalina McCoy. She is an endocrinologist at the Mayo Clinic in Rochester, Minn. Hypoglycemia (low blood sugar) is a serious potential complication of diabetes treatment. The researchers said it can worsen quality of life and has been linked with cardiovascular events, dementia and death. The researchers reviewed information from more than 31,500 American adults. All had stable and controlled type 2 diabetes. None was taking insulin. None had a prior history of severe ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Dementia, Glucophage, Novolog, Glipizide, Humalog, Hypoglycemia, Janumet, Glyburide, Lantus Solostar, Invokana, Levemir, Actos, Glimepiride, Novolin R, Amaryl, Mild Cognitive Impairment

Cost of Insulin Rises Threefold in Just a Decade: Study

Posted 5 Apr 2016 by Drugs.com

TUESDAY, April 5, 2016 – Americans with diabetes who rely on insulin to keep their blood sugar levels in check are facing sticker shock: A new study finds the price of insulin has tripled in only 10 years. Moreover, since 2010, per-person spending on insulin in the United States was more than spending on all other diabetes drugs, the study found. "The cost of insulin has risen rapidly over the last few years," said study senior author Philip Clarke, a professor of health economics at the University of Melbourne in Australia. Clarke added there should be an assessment to see whether this price hike is justifiable in terms of improved clinical outcomes. One reason for the price climb, he said, is a switch from human insulins to analog insulins, which cost more but may offer additional benefits. Also, doctors are more apt to prescribe insulin for people with type 2 diabetes now, Clarke ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Diabetes, Type 1, Januvia, Diabetic Neuropathy, Glucophage, Novolog, Glipizide, Humalog, Insulin Resistance, Bydureon, Byetta, Janumet, Diabetic Nerve Damage, Glyburide, Saxenda, Lantus Solostar

New Diabetes Cases Among Americans Drop for First Time in Decades: CDC

Posted 1 Dec 2015 by Drugs.com

TUESDAY, Dec. 1, 2015 – In a sign that Americans may finally be turning the corner in the fight against diabetes – and possibly obesity – federal health statistics released Tuesday show that the number of new cases of diabetes has dropped for the first time in decades. The decline wasn't sudden or dramatic. But, the number of new diabetes cases went from 1.7 million in 2009 to 1.4 million in 2014, according to the U.S. Centers for Disease Control and Prevention. "It seems pretty clear that incidence rates have now actually started to drop. Initially it was a little surprising because I had become so used to seeing increases everywhere we looked," CDC researcher Edward Gregg told The New York Times. The proportion of Americans with diabetes is still twice what it was in the early 1990s. And not every racial group has made strides against the blood sugar disease, which is often ... Read more

Related support groups: Obesity, Diabetes, Type 2, Metformin, Weight Loss, Insulin, Victoza, Lantus, Januvia, Glucophage, Novolog, Glipizide, Humalog, Bydureon, Byetta, Janumet, Glyburide, Saxenda, Lantus Solostar, Invokana, Levemir

Too Many Seniors With Diabetes Are Overtreated, Study Suggests

Posted 29 Oct 2015 by Drugs.com

THURSDAY, Oct. 29, 2015 – When it comes to treating seniors with diabetes, new research suggests that doctors often don't cut back on medications, even when treatment goals are surpassed. The study found that when people had potentially dangerous low blood sugar levels, just 27 percent had their medicines decreased. And when blood pressure treatments lowered blood pressure levels too much, just 19 percent saw a reduction in their medications. "As people get older, the risks of overtreating become greater, and the benefits become shorter. We have to start emphasizing that more isn't always better," said study author Dr. Jeremy Sussman, an assistant professor of internal medicine at the University of Michigan in Ann Arbor and a primary care doctor at the Ann Arbor VA System. The findings were published online Oct. 26 in the journal JAMA Internal Medicine. Practice guidelines generally ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Januvia, Glucophage, Novolog, Glipizide, Humalog, Bydureon, Byetta, Janumet, Saxenda, Glyburide, Lantus Solostar, Invokana, Levemir, Actos, Glimepiride

Tight Control of Type 2 Diabetes May Help Prevent Dementia

Posted 15 Sep 2015 by Drugs.com

TUESDAY, Sept. 15, 2015 – Keeping blood sugar levels in check may have a protective effect against dementia in people who have type 2 diabetes, new Swedish research suggests. "The positive association between [average blood sugar levels] and risk of dementia in fairly young patients with type 2 diabetes indicates a potential for prevention of dementia with improved blood sugar control," study author Dr. Aidin Rawshani, from the National Diabetes Register and Institute of Medicine in Gothenburg, Sweden, and colleagues wrote. However, the study wasn't able to definitively prove a cause-and-effect relationship between blood sugar levels and dementia; it was only able to show an association between these factors. The study included almost 350,000 people with type 2 diabetes. They were all registered in the Swedish National Diabetes Registry between January 2004 and December 2012. They had ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Dementia, Alzheimer's Disease, Glucophage, Novolog, Glipizide, Humalog, Janumet, Glyburide, Lantus Solostar, Invokana, Levemir, Actos, Glimepiride, Novolin R, Amaryl, Mild Cognitive Impairment

Insulin Pumps Nearly Halve Risk of Heart Disease Death for Type 1 Diabetics

Posted 19 Aug 2015 by Drugs.com

WEDNESDAY, Aug. 19, 2015 – People with type 1 diabetes who use insulin pumps seem to have a much lower risk of dying from heart disease or stroke prematurely than those who rely on multiple daily injections of insulin, new research suggests. "As done in Sweden at the time of this study, insulin pump treatment almost halved cardiovascular mortality," said study author Dr. Isabelle Steineck, from Aarhus University Hospital in Denmark. The researchers found a 45 percent lower risk of dying from heart disease early for insulin pump users. And the risk of dying early from heart disease or stroke was 42 percent lower for insulin pump users, while the risk of all-cause death was 27 percent lower during the seven-year study period. Because this was only an observational study, the authors can't say for sure that insulin pumps lowered death risk during the study, although they did find a ... Read more

Related support groups: Heart Disease, Insulin, Ischemic Stroke, Lantus, Diabetes, Type 1, Novolog, Humalog, Transient Ischemic Attack, Lantus Solostar, Levemir, Novolin R, Novolin N, Prevention of Cardiovascular Disease, Ischemic Stroke - Prophylaxis, Humulin N, Lantus Solostar Pen, Humulin R, NovoLog FlexPen, Cardiovascular Risk Reduction, Humalog KwikPen

Health Tip: Diabetes Can Take a Toll on Teeth and Mouth

Posted 10 Aug 2015 by Drugs.com

-- Diabetes, especially when uncontrolled, can cause damage to your mouth and teeth. The Mouthhealthy.org website says possible effects of diabetes on the teeth and mouth include: Dry mouth, due to decreased saliva production. Increased risk of cavities due to less saliva. Gingivitis, characterized by bleeding, inflamed gums. Difficulty tasting food. Slower healing of mouth wounds. Increased risk of infection. Among diabetic children. teeth emerging earlier than expected. Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Oral and Dental Conditions, Xerostomia, Victoza, Lantus, Toothache, Diabetes, Type 1, Januvia, Diabetic Neuropathy, Glucophage, Novolog, Burning Mouth Syndrome, Glipizide, Humalog, Insulin Resistance, Bydureon, Byetta, Janumet

People With Type 2 Diabetes Do Benefit From Blood Sugar Checks

Posted 5 Aug 2015 by Drugs.com

WEDNESDAY, Aug. 5, 2015 – Personalized blood sugar self-monitoring benefits people with type 2 diabetes even if they're not taking insulin, a new small study shows. Some experts have questioned the value of self-monitoring in this group, and many insurers – including Medicare – limit the reimbursement of blood sugar (glucose) testing strips to one a day for people with type 2 diabetes. This study included 11 people with type 2 diabetes who worked with the researchers to create personalized, structured self-monitoring blood glucose schedules. In most cases, self-monitoring twice a day was the most helpful in providing meaningful information about blood sugar levels. However, there was room for individualization based on a patient's type of lifestyle and needs. For example, a patient might check their blood sugar twice a day three days a week instead of once a day seven days a week, ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Januvia, Glucophage, Novolog, Glipizide, Humalog, Bydureon, Byetta, Janumet, Saxenda, Glyburide, Lantus Solostar, Invokana, Levemir, Actos, Glimepiride

High Blood Sugar May Boost Alzheimer's Risk

Posted 27 Jul 2015 by Drugs.com

MONDAY, July 27, 2015 – High blood sugar associated with prediabetes may increase the risk for Alzheimer's disease, a new study suggests. Researchers found that insulin resistance – higher-than-normal levels of blood sugar that often precede type 2 diabetes – was related to poorer performance on memory tests taken by late-middle-age adults. "The findings are interesting because people with diabetes are at increased risk for developing Alzheimer's disease, but we are only now learning why they may be at increased risk," said lead researcher Barbara Bendlin, an assistant professor of medicine at the University of Wisconsin-Madison. The study results suggest that insulin resistance could increase the risk for Alzheimer's disease by altering the way the brain uses sugar (glucose), which is its primary fuel, she said. However, "by altering insulin resistance in midlife, it may be possible ... Read more

Related support groups: Diabetes, Type 2, Insulin, Lantus, Alzheimer's Disease, Novolog, Humalog, Janumet, Lantus Solostar, Levemir, Pre-Diabetes, Novolin R, Novolin N, Humulin N, Lantus Solostar Pen, Humulin R, NovoLog FlexPen, Humalog KwikPen, Toujeo, ActoPlus Met, Apidra

Ask a Question

Further Information

Related Condition Support Groups

Diabetes, Type 2, Diabetes, Type 1

Toujeo Solostar Patient Information at Drugs.com